Ocugen
OCGN
Ocugen (OCGN) news
Recent news
OCugen - To manufacture commercial supply of OCU400 under supply agreement
AInvest Wire · 11h agoOCugen - Agreement includes up to $4 mln development payments, $255 mln sales milestones, 22% royalties
AInvest Wire · 11h agoOCugen - Expects OCU400 phase 3 topline data readout in Q1 2027
AInvest Wire · 11h agoOCugen and Roots Pharmaceutical complete license agreement for Ocu400 modifier gene therapy for retinitis pigmentosa in the Middle East and North Africa
AInvest Wire · 11h agoOCugen appoints industry executive Jolanda Crombach general manager of European affiliate
OCugen Inc. has announced the appointment of Jolanda Crombach as general manager of its European affiliate, effective immediately. Crombach brings extensive experience in the biotechnology and pharmaceutical sectors, having previously held leadership roles at several multinational firms. In her new…
AInvest Wire · Oct 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.